Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
Status:
Recruiting
Trial end date:
2023-06-25
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well topical afimoxifene works in treating patients with
breast cancer who have undergone radiation therapy on one breast. Topical afimoxifene is a
quick-drying medicated gel that may block the growth of breast cancer cells when applied to
the breast skin. The purpose of this research is to determine what effect, if any,
differences in skin type between women have on the delivery of topical afimoxifene to the
breast tissue, and whether radiation affects the delivery of topical afimoxifene to breast
tissue.